US EditionKashmik Formulation plans 50 per cent production capacity expansion and targets ₹100 crore revenue in FY26 - Express Pharma
Summary by Express Pharma
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Kashmik Formulation plans 50 per cent production capacity expansion and targets ₹100 crore revenue in FY26 - Express Pharma
Kashmik Formulation, a pharma manufacturing firm based in Ahmedabad, has announced plans to expand its production capacity, increase automation, and enhance its international footprint. The company has set a revenue target of ₹100 crore for the financial year 2025–26, following a 100 per cent year-on-year growth from ₹20 crore in FY23–24 to ₹40 crore in FY24–25. Currently operating at full capacity, Kashmik Formulation produces one crore tablets…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
